Company overview
Uniqsis designs and manufactures benchtop continuous flow chemistry systems for pharmaceutical R&D and chemical synthesis. Their modular reactors, including FlowSyn and FlowLab, support scalable reactions from mg to kg scale, high temperatures up to 300°C, and pressures to 1400 psi. These systems enable automated, efficient processes for catalysis, library synthesis, and superheated reactions used by major pharma companies.
Flow Chemistry Reactors is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include flow chemistry, continuous flow reactors, uniqsis flowsyn, pharma r&d equipment, chemical synthesis systems.
Products and technologies associated with Flow Chemistry Reactors include Equipment, Synthesis — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.uniqsis.com
- Markets served
- United States & Americas
- Keywords
- flow chemistry, continuous flow reactors, uniqsis flowsyn, pharma r&d equipment, chemical synthesis systems
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What flow chemistry systems does Uniqsis offer?
- Uniqsis offers modular systems like FlowSyn (fully integrated benchtop reactor), FlowLab (affordable entry-level with manual/automated control), and FlowLab Column (2-channel for high-temperature/pressure catalysis), supporting reactions from ambient to 300°C and up to 1400 psi.
- What capabilities do Uniqsis reactors provide for pharma R&D?
- Systems handle extensive chemistries from mg to kg scale, including microwave-like conditions up to 260°C, sub-ambient cooling to -70°C, automation for multi-step sequences, and library synthesis, designed by chemists for efficiency and scalability.
- What industries and regions use Uniqsis equipment?
- Uniqsis FlowSyn is used by major pharmaceutical companies and academic labs worldwide for continuous flow chemistry; distributors like Interchim (Europe) and Asynt support global access.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
